Skip to product information
1 of 1

FITC Mouse Anti-Human HLA-DR, DP, DQ Antibody (Tu39)

FITC Mouse Anti-Human HLA-DR, DP, DQ Antibody (Tu39)

Catalog Number: S0B81016 Application: FCM Reactivity: Hu Conjugation: FITC Brand: Starter
Price:
Regular price $145 USD
Regular price Sale price $145 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Mouse
Antigen HLA-DR, DP, DQ
Location Lysosome, Endosome, Cell membrane, Endoplasmic reticulum, Synapse
Accession P01903、P20036、P01906
Clone Number Tu39
Antibody Type Mouse mAb
Isotype Control S0B5453
Application FCM
Reactivity Hu
Positive Sample Human peripheral blood cells
Purification Protein A
Concentration 0.2 mg/ml
Conjugation FITC
Physical Appearance Liquid
Storage Buffer

PBS, 1% BSA, 0.09% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, 2 to 8 °C as supplied

Dilution


application dilution species
FCM 5μl per million cells in 100μl volume Hu

Background

HLA-DR、DP、DQ are the three classical class II human leukocyte antigen (HLA) isotypes, encoded within the HLA-D region of the major histocompatibility complex. All three are heterodimeric glycoproteins composed of an α chain and a β chain that present peptide antigens to CD4⁺ T cells, but they differ in their gene organization, polymorphism, expression, and intracellular assembly requirements. HLA-DR is the most extensively studied and most polymorphic isotype; its DRA gene is essentially non-polymorphic while the DRB1 locus harbors the greatest allelic diversity in the class II region, and its efficient peptide loading is well recognized to depend on both invariant chain (Ii) and HLA-DM. HLA-DQ is formed by polymorphic DQA1 and DQB1 chains and is strongly linked to celiac disease and other autoimmune conditions; unlike DR, DQ molecules can form SDS-stable dimers supported by Ii even in the absence of HLA-DM. HLA-DP has a more restricted peptide repertoire and less well-defined roles in autoimmunity, though certain DP alleles are risk factors for myasthenia gravis and berylliosis; uniquely, HLA-DP can also form stable dimers with HLA-DM alone and exhibits distinct chaperone requirements compared to DR and DQ.

Picture

FC

Flow cytometric analysis of Human HLA-DR, DP, DQ expression on Human Peripheral Blood cells. Human Peripheral Blood cells were stained with Brilliant Violet 421™ Mouse Anti-Human CD19 Antibody and either FITC Mouse IgG2a, κ Isotype Control (left panel) or SDT FITC Mouse Anti-Human HLA-DR Antibody (right panel) at 5 μl/test. Flow cytometry and data analysis were performed using Agilent NovoCyte Quanteon and FlowJo™ software.